Member Info for 54retiresoon

3 buys at. 55p Inc one at 1.1 million shares

1/2 million, latest buy. 55

Buy at. 54 recorded at 10

I would agree with Iglu that 10m is more likely the sum needed to repay Midcap, complete the refit at San Antonio and provide the funds to take us through to break even which cannot be too far away. It would be a shame to be taken over when so close to becoming profitable in our own right. So much potential with their world leading products.

John Samuel is stepping down as Executive Chair.

Does the cheap loans announced by the Chancellor allow Trx to solve their current funding problem?

Diabetic Foot Ulcer Treatment Market Worth $11.16 Billion at 6.8% CAGR; Rise in Clinical Trials to Augment Market, says Fortune Business Insights™
Key Companies Covered in the Diabetic Foot Ulcer (DFU) Treatment Market Research Report are Integra LifeSciences Corporation., Smith & Nephew, Tissue Regenix, Coloplast Corp, B. Braun Melsungen AG, 3M, Cardinal Health., ConvaTec Group Plc, Mölnlycke Health Care AB. and other key market players.